Skip to content
Trial Eligibility
Menu

Cardiac Power Output in Cardiogenic Shock Patients

NCT05700617

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Heart Failure
  • Cardiogenic Shock

Eligibility basics and study details

Study type
Interventional
Phase
Early Phase 1
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Chicago
Last updated on ClinicalTrials.gov
August 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • The University of Chicago · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.